FDA-ordered studies of many drugs, devices on the market are not done

When the Food and Drug Administration was deciding whether to approve the drug Tavneos several years ago to treat a set of rare autoimmune diseases, agency experts argued that would be a mistake, according to FDA records....

Redirecting to full article...